HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F Giles Selected Research

Cytopenia

10/2001Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F Giles Research Topics

Disease

7BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2017 - 10/2006
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2012 - 01/2000
5Neoplasms (Cancer)
12/2021 - 04/2001
5Leukemia
01/2020 - 02/2000
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2007 - 01/2001
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
06/2007 - 02/2000
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2001 - 04/2001
1Prostatic Neoplasms (Prostate Cancer)
01/2020
1Fibrosis (Cirrhosis)
11/2014
1Primary Myelofibrosis (Myelosclerosis)
11/2014
1Hyperbilirubinemia
11/2007
1Blast Crisis (Blast Phase)
10/2006
1Hairy Cell Leukemia
11/2004
1Refractory Anemia with Excess of Blasts (RAEM)
11/2002
1Pure Red-Cell Aplasia
10/2001
1Anemia
10/2001
1Cytopenia
10/2001
1Thrombocytopenia (Thrombopenia)
10/2001
1Acute Promyelocytic Leukemia
07/2001
1Mucositis
07/2001
1Hematologic Neoplasms (Hematological Malignancy)
01/2001
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
02/2000

Drug/Important Bio-Agent (IBA)

5Phosphotransferases (Kinase)IBA
11/2014 - 10/2006
4nilotinibFDA Link
10/2017 - 11/2007
4Cytarabine (Cytosar-U)FDA LinkGeneric
09/2012 - 02/2000
3Imatinib Mesylate (Gleevec)FDA Link
04/2013 - 10/2006
2Daunorubicin (Cerubidine)FDA LinkGeneric
09/2012 - 07/2001
2Topoisomerase I InhibitorsIBA
01/2001 - 02/2000
1Glycogen Synthase KinasesIBA
12/2021
1Histone MethyltransferasesIBA
01/2020
1Lysine (L-Lysine)FDA Link
01/2020
1Histones (Histone)IBA
01/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2014
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2014
1TOR Serine-Threonine KinasesIBA
11/2014
1Janus Kinase InhibitorsIBA
11/2014
1fms-Like Tyrosine Kinase 3IBA
10/2012
1midostaurinIBA
09/2012
1BilirubinIBA
11/2007
1Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA
11/2007
1Uridine Diphosphate (UDP)IBA
11/2007
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
06/2007
1troxacitabineIBA
06/2007
1Proteins (Proteins, Gene)FDA Link
06/2007
1InterferonsIBA
10/2006
1DNA (Deoxyribonucleic Acid)IBA
01/2003
1Annexin A5IBA
11/2002
1Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2001
1fludarabineIBA
10/2001
1Hemoglobins (Hemoglobin)IBA
10/2001
1acivicin (AT 125)IBA
07/2001
1Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2001
1Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
04/2001
1Cyclin D1IBA
04/2001
1irofulvenIBA
01/2001
1acylfulveneIBA
01/2001
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2000
1Topotecan (Hycamtin)FDA LinkGeneric
02/2000
1Vincristine (Oncovin)FDA LinkGeneric
01/2000
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2000
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2000

Therapy/Procedure

5Therapeutics
11/2014 - 10/2001
1Drug Therapy (Chemotherapy)
09/2012